These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1170715)

  • 1. Actions of dopaminergic agonists on motor function.
    Costall B; Naylor RJ
    Adv Neurol; 1975; 9():285-97. PubMed ID: 1170715
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 3. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):71-81. PubMed ID: 4280019
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration.
    Klawans HL; Margolin DI; Dana N; Crosset P
    J Neurol Sci; 1975 Jul; 25(3):283-9. PubMed ID: 1171935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias.
    Klawans HL; Crossett P; Dana N
    Adv Neurol; 1975; 9():105-12. PubMed ID: 1170714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dopamine-like compounds on stereotypy and locomotor activity in atropinized rats.
    Grabowska M
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):753-61. PubMed ID: 1241267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 11. Pre- and post-synaptic actions of apomorphine: differentiation by rotatory effects in normal rats.
    Glick SD; Jerussi TP; Cox RD; Fleisher LN
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):303-7. PubMed ID: 557962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behavioural effects of (+)-amphetamine and apomorphine in the marmoset [proceedings].
    Ridley RM; Crow TJ
    Br J Pharmacol; 1978 Mar; 62(3):393P. PubMed ID: 416868
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of baclofen and aminooxyacetic acid on the action of drugs stimulating the dopaminergic system.
    Sypniewska M
    Pol J Pharmacol Pharm; 1978; 30(6):755-66. PubMed ID: 573471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supersensitivity following repeated administration of dopaminergic agonists.
    Westermann KH
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):58-63. PubMed ID: 6889805
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of dopaminergic agonists upon body temperature and behavior of spontaneously hypertensive and normotensive rats.
    Martin JR; Quock RM
    Proc West Pharmacol Soc; 1978; 21():451-3. PubMed ID: 567806
    [No Abstract]   [Full Text] [Related]  

  • 16. Behavioral effects of dopamine agonists increase with age.
    Smith RC; Leelavathi DE; Lauritzen AM
    Commun Psychopharmacol; 1978; 2(1):39-43. PubMed ID: 566185
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa-induced dopamine receptor hypersensitivity.
    Klawans HL; Goetz C; Nausieda PA; Weiner WJ
    Trans Am Neurol Assoc; 1977; 102():80-3. PubMed ID: 616121
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of circling models for the detection of antiparkinson activity.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975; 41(1):57-64. PubMed ID: 1091939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
    Klawans HL; Margolin DI
    Arch Gen Psychiatry; 1975 Jun; 32(6):725-32. PubMed ID: 1130936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.